PDS Biotechnology (PDSB) Misses Q3 EPS by 4c; Reports Cash and Cash Equivalents of $69.7M

PDS Biotechnology (NASDAQ: PDSB) reported Q3 EPS of ($0.24), $0.04 worse than the analyst estimate of ($0.20).

For earnings history and earnings-related data on PDS Biotechnology (PDSB) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Cummins wins battery storage contract for U.S. data center project
• Home Depot beats estimates, reaffirms fiscal 2026 guidance